COMMUNIQUÉS West-GlobeNewswire

-
REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System
17/07/2024 -
Dror Ortho-Design, Inc. Launches New ZSMILE Product Brand
17/07/2024 -
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024
17/07/2024 -
On Heels of Family Forward NC Certification, Aeroflow Health Will Employ a Record 900 in Coming Months
17/07/2024 -
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
17/07/2024 -
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
17/07/2024 -
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
17/07/2024 -
Pour la première fois au Moyen-Orient, une chirurgie endoscopique de l'utérus pratiquée au KFSHRC corrige une malformation de la moelle épinière chez un fœtus de 26 semaines
17/07/2024 -
Bon Secours Mercy Health and Philips sign multi-year strategic collaboration
17/07/2024 -
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024
17/07/2024 -
Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
17/07/2024 -
CervoMed to Participate in the Emerging Growth Conference
17/07/2024 -
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
17/07/2024 -
What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk
17/07/2024 -
HealthLynked Expands Telemedicine Nationwide
17/07/2024 -
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
17/07/2024 -
Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
17/07/2024 -
STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found Safe and Effective in Study Published in Peer Reviewed Journal
17/07/2024 -
Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease
17/07/2024
Pages